Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.4/5

Recordati SpA (REC IM)

20
Analysis
Health Care • Italy
Recordati S.p.A. manufactures pharmaceuticals. The Company researches, develops, manufactures, and markets prescription and non-prescription pharmaceuticals, pharmaceutical chemicals, therapeutic products, and rare disease treatments. The Company sells its products throughout the world.
more
bullish•Recordati SpA
•07 Jul 2025 21:07

Recordati -Dual Engine Strategy Powers Rare Disease Dominance & SPC Stability!

Recordati has reported positive momentum in its first quarter of 2025 results, showing an 11.9% increase in net revenue compared to the previous...

Logo
826 Views
Share
bullish•Recordati SpA
•07 Oct 2024 03:15

Recordati - ESG Report - Lucror Analytics

Lucror Analytics' ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable). We assess Recordati's ESG as...

Logo
242 Views
Share
bearish•ams AG
•27 Sep 2024 10:30

Europe HY Trade Book - September 2024 - Lucror Analytics

The Europe HY Trade Book for September 2024 includes current trade recommendations drawn from our European HY coverage universe, along with...

Logo
409 Views
Share
bearish•ams AG
•28 Aug 2024 19:00

Europe HY Trade Book - August 2024 - Lucror Analytics

The Europe HY Trade Book for August 2024 includes current trade recommendations drawn from our European HY coverage universe, along with...

Logo
95 Views
Share
x